verapamil and glucagon-like peptide 1

verapamil has been researched along with glucagon-like peptide 1 in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Proft, R; Dejonghe, S; Gorus, F; Ling, Z; Pipeleers, D; Schuit, F; Winnock, F	1
Briaud, I; Dickson, LM; Lingohr, MK; Rhodes, CJ; Wrede, CE	1
Cali, JJ; Delmeire, D; Flamez, D; Hinke, SA; Pipeleers, D; Schuit, F	1
Bamba, M; Eiki, J; Iino, T; Ito, S; Kanatani, A; Nagano, N; Nagase, T; Nishimura, T; Ohyama, S; Saeki, K; Sasaki, K; Sato, Y; Takayenoki-Iino, Y; Watanabe, H; Yada, T; Yonemoto, M	1
Guerra, ML; Hockerman, GH; Jarrard, RE; Lange, AM; Pratt, EP; Salyer, AE; Soderling, IM; Wang, Y	1
Andersen, D; Hansen, DL; Holst, JJ; Højager, A; Kielgast, UL; Worm, D; Øhrstrøm, CC	1

Trials

1 trial(s) available for verapamil and glucagon-like peptide 1

Article	Year
Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide. Diabetes, obesity & metabolism, 2019, Volume: 21, Issue:9 Topics: Acarbose; Adult; Blood Glucose; Blood Glucose Self-Monitoring; Cross-Over Studies; Female; Gastric Bypass; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Hypoglycemic Agents; Liraglutide; Male; Middle Aged; Obesity, Morbid; Postoperative Complications; Postprandial Period; Sitagliptin Phosphate; Somatostatin; Treatment Outcome; Verapamil	2019

Article

Year

Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide.

Diabetes, obesity & metabolism, 2019, Volume: 21, Issue:9

Topics: Acarbose; Adult; Blood Glucose; Blood Glucose Self-Monitoring; Cross-Over Studies; Female; Gastric Bypass; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Hypoglycemic Agents; Liraglutide; Male; Middle Aged; Obesity, Morbid; Postoperative Complications; Postprandial Period; Sitagliptin Phosphate; Somatostatin; Treatment Outcome; Verapamil

2019

Other Studies

5 other study(ies) available for verapamil and glucagon-like peptide 1

Article	Year
Correlation between GABA release from rat islet beta-cells and their metabolic state. American journal of physiology. Endocrinology and metabolism, 2002, Volume: 282, Issue:4 Topics: 1-Methyl-3-isobutylxanthine; 2,4-Dinitrophenol; Adenosine Triphosphate; Animals; Calcium; Culture Media, Conditioned; Cycloheximide; Diazoxide; gamma-Aminobutyric Acid; Glucagon; Glucagon-Like Peptide 1; Glucose; Glutamate Decarboxylase; Glyburide; Islets of Langerhans; Male; Mannoheptulose; Oxidation-Reduction; Peptide Fragments; Protein Precursors; Rats; Rats, Wistar; Verapamil	2002
Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic beta-cells. Diabetes, 2003, Volume: 52, Issue:4 Topics: Animals; Calcium; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Humans; Islets of Langerhans; Isoquinolines; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Proteins c-raf; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Sulfonamides; Verapamil	2003
Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1. Diabetologia, 2003, Volume: 46, Issue:10 Topics: Adenylyl Cyclases; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calmodulin; Cells, Cultured; Cyclic AMP; Drug Combinations; Drug Synergism; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; GTP-Binding Protein alpha Subunits, Gs; Insulin; Islets of Langerhans; Male; Peptide Fragments; Protein Precursors; Rats; Rats, Wistar; Receptors, Glucagon; Signal Transduction; Verapamil	2003
A selective small molecule glucagon-like peptide-1 secretagogue acting via depolarization-coupled Ca(2+) influx. The Journal of endocrinology, 2009, Volume: 201, Issue:3 Topics: Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cells, Cultured; Drug Evaluation, Preclinical; Enteroendocrine Cells; Female; Glucagon-Like Peptide 1; Isoindoles; Male; Membrane Potentials; Mice; Oxazoles; PC12 Cells; Pregnancy; Rats; Rats, Wistar; Secretory Pathway; Substrate Specificity; Verapamil	2009
Uncoupling of Cav1.2 from Ca(2+)-induced Ca(2+) release and SK channel regulation in pancreatic β-cells. Molecular endocrinology (Baltimore, Md.), 2014, Volume: 28, Issue:4 Topics: Action Potentials; Animals; Calcium; Calcium Channels, L-Type; Cell Fractionation; Centrifugation, Density Gradient; Cyclic AMP; Endocytosis; Endoplasmic Reticulum; Eukaryotic Initiation Factor-3; Glucagon-Like Peptide 1; Glucose; Immunoprecipitation; Insulin; Insulin Secretion; Insulin-Secreting Cells; Intracellular Space; Ion Channel Gating; Male; Protein Structure, Secondary; ras GTPase-Activating Proteins; Rats; Rats, Wistar; Small-Conductance Calcium-Activated Potassium Channels; Tolbutamide; Verapamil	2014